Predict your next investment

Corporation
HEALTHCARE | Biotechnology
beamtx.com

See what CB Insights has to offer

Founded Year

2017

Stage

IPO | IPO

Total Raised

$222M

Date of IPO

2/6/2020

Market Cap

4.90B

Stock Price

94.87

About Beam Therapeutics

Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA.

Beam Therapeutics Headquarter Location

26 Landsdowne Street 2nd Floor

Cambridge, Massachusetts, 02139,

United States

Latest Beam Therapeutics News

Prime Medicine’s $315 Million Financing

Jul 15, 2021

Prime Medicine™ announced its launch and funding rounds totaling $315 million. Prime Medicine is a biotechnology company founded to deliver on the promise of Prime Editing, a versatile gene editing technology that can truly “search and replace” to restore normal genetic function and address the fundamental causes of disease. Prime Medicine benefits from a relationship with Beam Therapeutics. Prime and Beam both emerged from the laboratory of Dr. David R. Liu and have built a partnership to form a collaborative approach to fighting disease and accelerating the development of Prime Editing to deliver therapies for patients. In the areas of partnership, Prime Medicine and Beam share research, expertise, and intellectual property for assays, know-how, delivery, and manufacturing. The financing comprised a $115 million Series A and a $200 million Series B financing approximately nine months after the company began operations. The funds raised will be used to continue building the company, rapidly advance towards clinical indications, expand the capabilities of the platform, and to further enhance the exceptional promise of Prime Editing. The Goodwin team was led by Kingsley Taft (Picture), Erin Svokos, and Mulon Luo, and included Nathan Needle and Jay Yaworski.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Beam Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Beam Therapeutics is included in 4 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,726 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

S

Synthetic Biology

235 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.

R

Regenerative Medicine

1,708 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Beam Therapeutics Patents

Beam Therapeutics has filed 2 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Genetics
  • Molecular biology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/16/2018

Small nuclear RNA, Molecular biology, Genetics, Biotechnology, Genetic engineering

Application

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/16/2018

00/00/0000

Grant Date

00/00/0000

Title

Subscribe to see more

Related Topics

Small nuclear RNA, Molecular biology, Genetics, Biotechnology, Genetic engineering

Subscribe to see more

Status

Application

Subscribe to see more

Beam Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Beam Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.